CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-25 | Verratti Mark President, Myriad Neuroscience | Shares withheld for taxes | −1,082 | $34.81 | $38K | 156,048 |
| 2021-08-25 | LANCHBURY JERRY S Chief Scientific Officer | Shares withheld for taxes | −2,233 | $34.81 | $78K | 230,317 |
| 2021-08-24 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +30,000 | $27.07 | $812K | 262,550 |
| 2021-08-24 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −30,000 | $35.57 | $1.1M | 232,550 |
| 2021-08-24 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 0 | ||
| 2021-08-23 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +10,000 | $27.07 | $271K | 242,550 |
| 2021-08-23 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −10,000 | $35.57 | $356K | 232,550 |
| 2021-08-23 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +40,000 | $27.07 | $1.1M | 272,550 |
| 2021-08-23 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −40,000 | $35.07 | $1.4M | 232,550 |
| 2021-08-23 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −10,000 | 70,000 | ||
| 2021-08-23 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −40,000 | 30,000 | ||
| 2021-08-13 | DIAZ PAUL J President and CEO | Shares withheld for taxes | −58,820 | $32.79 | $1.9M | 400,049 |
| 2021-08-10 | Riggsbee Richard Bryan Chief Financial Officer | Gift | −3,250 | 321,692 | ||
| 2021-08-05 | Phanstiel S. Louise Director | Exercise or conversion | +30,000 | $25.39 | $762K | 109,527 |
| 2021-08-05 | Phanstiel S. Louise Director | Sale | −47,881 | $35.04 | $1.7M | 61,646 |
| 2021-08-05 | Phanstiel S. Louise Director | Exercise or conversion | +30,000 | $21.29 | $639K | 91,646 |
| 2021-08-05 | Phanstiel S. Louise Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 0 | ||
| 2021-08-05 | Phanstiel S. Louise Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 0 | ||
| 2021-08-05 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +28,225 | $27.07 | $764K | 260,775 |
| 2021-08-05 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −28,225 | $35.57 | $1.0M | 232,550 |
Page 23 of 35 · 689 trades